Epithelial cells of the female reproductive tract (FRT) participate in the initial innate immunity against
viral infections.
Poly(dA:dT) is a synthetic analog of B form double-stranded (
ds) DNA which can activate the
interferon (IFN) signaling pathway-mediated
antiviral immunity through
DNA-dependent RNA Polymerase III. Here we investigated whether
poly(dA:dT) could inhibit herpes simplex virus type 2 (HSV-2)
infection of human cervical epithelial cells (End1/E6E7). We demonstrated that
poly(dA:dT) treatment of End1/E6E7 cells could significantly inhibit HSV-2
infection. Mechanistically,
poly(dA:dT) treatment of the cells induced the expression of the intracellular IFNs and the multiple
antiviral IFN-stimulated genes (ISGs), including IFN-stimulated gene 15 (ISG15), IFN-stimulated gene 56 (ISG56), 2'-5'-oligoadenylate
synthetase 1 (OAS1), 2'-5'-oligoadenylate
synthetase 2 (OAS2), myxovirus resistance
protein A (MxA), myxovirus resistance
protein B (MxB), virus inhibitory
protein, endoplasmic reticulum-associated, IFN-inducible (Viperin), and guanylate
binding protein 5 (GBP5). Further investigation showed that the activation of RIG-I was largely responsible for
poly(dA:dT)-mediated HSV-2 inhibition and IFN/ISGs induction in the cervical epithelial cells, as RIG-I knockout abolished the
poly(dA:dT) actions. These observations demonstrate the importance for design and development of AT-rich dsDNA-based intervention strategies to control HSV-2 mucosal transmission in FRT.